G. Box

677 total citations
16 papers, 540 citations indexed

About

G. Box is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, G. Box has authored 16 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Molecular Biology. Recurrent topics in G. Box's work include HER2/EGFR in Cancer Research (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). G. Box is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). G. Box collaborates with scholars based in United Kingdom and Russia. G. Box's co-authors include S. A. Eccles, William Court, Helmout Modjtahedi, Christopher Dean, Elisabeth A. Bone, Peter de Nully Brown, William A. Thomas, Pornchai O‐charoenrat, P. Rhys‐Evans and J Sandle and has published in prestigious journals such as British Journal of Cancer, International Journal of Cancer and European Journal of Cancer.

In The Last Decade

G. Box

16 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Box United Kingdom 10 337 236 187 115 69 16 540
S. G. Shering Ireland 8 200 0.6× 175 0.7× 140 0.7× 48 0.4× 34 0.5× 11 484
Gemma Shay United States 9 320 0.9× 299 1.3× 242 1.3× 52 0.5× 72 1.0× 10 637
Michelle D. Martin United States 9 499 1.5× 348 1.5× 375 2.0× 50 0.4× 88 1.3× 14 796
Jay Overholser United States 11 358 1.1× 439 1.9× 157 0.8× 138 1.2× 117 1.7× 16 767
Shiro Kataoka Japan 13 219 0.6× 480 2.0× 103 0.6× 78 0.7× 33 0.5× 27 717
Hemanth J. Varghese Canada 7 276 0.8× 208 0.9× 162 0.9× 22 0.2× 60 0.9× 8 458
Aaron Sabbota United States 7 260 0.8× 155 0.7× 188 1.0× 33 0.3× 83 1.2× 11 424
Yvette van Hensbergen Netherlands 12 348 1.0× 301 1.3× 155 0.8× 47 0.4× 57 0.8× 22 666
Sean E. Sissons United States 8 201 0.6× 242 1.0× 145 0.8× 29 0.3× 75 1.1× 11 476
M L Lamelas Spain 11 244 0.7× 200 0.8× 283 1.5× 27 0.2× 53 0.8× 12 547

Countries citing papers authored by G. Box

Since Specialization
Citations

This map shows the geographic impact of G. Box's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Box with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Box more than expected).

Fields of papers citing papers by G. Box

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Box. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Box. The network helps show where G. Box may publish in the future.

Co-authorship network of co-authors of G. Box

This figure shows the co-authorship network connecting the top 25 collaborators of G. Box. A scholar is included among the top collaborators of G. Box based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Box. G. Box is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Workman, Paul, Paul A. Clarke, Robert te Poele, et al.. (2022). Discovery and validation of biomarkers to support clinical development of NXP800: A first-in-class orally active, small-molecule HSF1 pathway inhibitor. European Journal of Cancer. 174. S35–S35. 4 indexed citations
2.
Court, William, et al.. (2006). Role of the Brk tyrosine kinase in breast cancer progression. Breast Cancer Research. 8(S2). 1 indexed citations
3.
4.
O‐charoenrat, Pornchai, Helmout Modjtahedi, P. Rhys‐Evans, et al.. (2000). Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.. PubMed. 60(4). 1121–8. 128 indexed citations
5.
Mistry, Prakash, Jane A. Plumb, Sue Eccles, et al.. (1999). In vivo efficacy of XR9051, a potent modulator of P-glycoprotein mediated multidrug resistance. British Journal of Cancer. 79(11-12). 1672–1678. 17 indexed citations
6.
Haar, Gail ter, et al.. (1998). Treatment of implanted liver tumors with focused ultrasound. Ultrasound in Medicine & Biology. 24(9). 1475–1488. 28 indexed citations
7.
Eccles, S. A., G. Box, William Court, et al.. (1996). Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94).. PubMed. 56(12). 2815–22. 155 indexed citations
8.
Smith, Timothy, S. A. Eccles, G. Box, et al.. (1996). Phosphocholine and choline content of rat sarcoma cells grown in the presence and absence of serum.. PubMed. 16(3B). 1389–92. 7 indexed citations
9.
Dean, Christopher, et al.. (1994). Immunotherapy with antibodies to the EGF receptor. International Journal of Cancer. 57(S8). 103–107. 20 indexed citations
10.
Eccles, S. A., G. Box, William Court, J Sandle, & Christopher Dean. (1994). Preclinical models for the evaluation of targeted therapies of metastatic disease. Cell Biophysics. 24-25(1-3). 279–291. 25 indexed citations
11.
Modjtahedi, Helmout, S. A. Eccles, J Sandle, et al.. (1994). Differentiation or immune destruction: two pathways for therapy of squamous cell carcinomas with antibodies to the epidermal growth factor receptor.. PubMed. 54(7). 1695–701. 54 indexed citations
12.
Modjtahedi, Helmout, S. A. Eccles, G. Box, Jennifer Styles, & Christopher Dean. (1993). Antitumor activity of combinations of antibodies directed against different epitopes on the extracellular domain of the human EGF receptor. Cell Biophysics. 22(1-3). 129–146. 17 indexed citations
13.
Modjtahedi, Helmout, et al.. (1993). Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction. British Journal of Cancer. 67(2). 254–261. 58 indexed citations
14.
McKay, I., et al.. (1993). Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumour. British Journal of Cancer. 68(2). 295–302. 9 indexed citations
15.
Eccles, S. A., G. Box, William Court, Mary Collins, & Christopher Dean. (1993). Monoclonal antibodies for the treatment of metastases. Cell Biophysics. 22(1-3). 165–187. 2 indexed citations
16.
Dean, Christopher, S. A. Eccles, M Valeri, et al.. (1993). Rat MAbs to the product of the c-erbB-2 proto-oncogene for diagnosis and therapy in breast cancer. Cell Biophysics. 22(1-3). 111–127. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. G. Shering Breakdown of academic impact, for papers by Gemma Shay Breakdown of academic impact, for papers by Michelle D. Martin Breakdown of academic impact, for papers by Jay Overholser Breakdown of academic impact, for papers by Shiro Kataoka Breakdown of academic impact, for papers by Hemanth J. Varghese Breakdown of academic impact, for papers by Aaron Sabbota Breakdown of academic impact, for papers by Yvette van Hensbergen Breakdown of academic impact, for papers by Sean E. Sissons Breakdown of academic impact, for papers by M L Lamelas
Rankless by CCL
2026